What does BETAMEDICS do?

BETAMEDICS is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Public Limited, started on 9 November 2015, 1 establishment.

What is the address of BETAMEDICS?

The registered office of BETAMEDICS is located at Sint-Martinusstraat 15, 8800 Roeselare.

Is BETAMEDICS still active?

Yes. According to the CBE (29 October 2026) BETAMEDICS is active, legal situation “Normale toestand”, started on 9 November 2015.

Is BETAMEDICS registered on Peppol?

Yes, BETAMEDICS is registered on the Peppol network with ID 0208:0642736252.

What is the enterprise number of BETAMEDICS?

The enterprise number of BETAMEDICS is BE0642736252.

When was BETAMEDICS founded?

BETAMEDICS was founded on 9 November 2015.

Who are the directors of BETAMEDICS?

According to the 2025 annual accounts, the directors of BETAMEDICS are: Tiemen Darras, Lies Sobry.

Is BETAMEDICS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 November 2015; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did BETAMEDICS make in 2025?

BETAMEDICS recorded a loss after taxes of € 17,276 in financial year 2025.

What is the revenue of BETAMEDICS?

As a small company, BETAMEDICS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 96,049.

How much does an employee at BETAMEDICS earn?

The average wage cost per full-time employee at BETAMEDICS was € 44,700 in 2025: staff costs of € 44,688 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BETAMEDICS have?

According to the 2025 annual accounts, BETAMEDICS has 1 full-time equivalents (FTE).

Does BETAMEDICS have a website?

Yes, BETAMEDICS has a website at betamedics.com.

BETAMEDICS (Public Limited) - Roeselare - BE0642736252

Dossier BETAMEDICS, printed on 29 October 2026 from databakkes.be/en/0642736252/betamedics. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

BETAMEDICS from Roeselare, company number BE0642736252, closed financial year 2025 with a result of € -17,276 after tax. For that financial year BETAMEDICS recorded a gross margin of € 96,049 and equity of € 1 million. Compared with financial year 2024, the result moved from € -113,775 to € -17,276. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Healthy

€ 1 million

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -17,276

▲ 85 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 72,362

▼ 46% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 254,383.

People and assets in 2025

Full-time equivalents

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 44,688

▲ 35% vs 2024

€ 44,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 102,694

▲ 47% vs 2024

Of which on lease € 37,257.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 585,959

▼ 5% vs 2024

€ 84,547 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 24,321

▼ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,818

▲ 52% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 189,348 Gross margin 2022: € 189,348 First fiscal year in the series	€ -6,711 Gross margin 2023: € -6,711 ▼ € 196,059 vs 2022 (€ 189,348) Unfavourable step	€ -17,139 Gross margin 2024: € -17,139 ▼ € 10,428 vs 2023 (€ -6,711) Unfavourable step	€ 96,049 Gross margin 2025: € 96,049 ▲ € 113,188 vs 2024 (€ -17,139) Favourable step	▲ € 113,188
Profit after taxes	€ 81,172 Profit after taxes 2022: € 81,172 First fiscal year in the series	€ -120,948 Profit after taxes 2023: € -120,948 ▼ € 202,120 vs 2022 (€ 81,172) Unfavourable step	€ -113,775 Profit after taxes 2024: € -113,775 ▲ € 7,173 vs 2023 (€ -120,948) Favourable step	€ -17,276 Profit after taxes 2025: € -17,276 ▲ € 96,499 vs 2024 (€ -113,775) Favourable step	▲ € 96,499
Equity	€ 1,256,382 Equity 2022: € 1,256,382 First fiscal year in the series	€ 1,135,434 Equity 2023: € 1,135,434 ▼ 10% vs 2022 (€ 1,256,382) Unfavourable step	€ 1,021,659 Equity 2024: € 1,021,659 ▼ 10% vs 2023 (€ 1,135,434) Unfavourable step	€ 1,004,383 Equity 2025: € 1,004,383 ▼ 2% vs 2024 (€ 1,021,659) Unfavourable step	▼ 2%
Total debts	€ 921,993 Total debts 2022: € 921,993 First fiscal year in the series	€ 775,954 Total debts 2023: € 775,954 ▼ 16% vs 2022 (€ 921,993) Favourable step	€ 661,151 Total debts 2024: € 661,151 ▼ 15% vs 2023 (€ 775,954) Favourable step	€ 625,099 Total debts 2025: € 625,099 ▼ 5% vs 2024 (€ 661,151) Favourable step	▼ 5%
Cash	€ 969,655 Cash 2022: € 969,655 First fiscal year in the series	€ 155,822 Cash 2023: € 155,822 ▼ 84% vs 2022 (€ 969,655) Unfavourable step	€ 133,647 Cash 2024: € 133,647 ▼ 14% vs 2023 (€ 155,822) Unfavourable step	€ 72,362 Cash 2025: € 72,362 ▼ 46% vs 2024 (€ 133,647) Unfavourable step	▼ 46%
Land & buildings	€ 1,129,797 Land & buildings 2022: € 1,129,797 First fiscal year in the series	€ 1,131,765 Land & buildings 2023: € 1,131,765 Unchanged (€ 1,129,797) Unchanged	€ 1,103,256 Land & buildings 2024: € 1,103,256 ▼ 3% vs 2023 (€ 1,131,765) Unchanged	€ 1,067,826 Land & buildings 2025: € 1,067,826 ▼ 3% vs 2024 (€ 1,103,256) Unchanged	▼ 3%
Retained profit	€ 506,382 Retained profit 2022: € 506,382 First fiscal year in the series	€ 385,434 Retained profit 2023: € 385,434 ▼ 24% vs 2022 (€ 506,382) Unfavourable step	€ 271,659 Retained profit 2024: € 271,659 ▼ 30% vs 2023 (€ 385,434) Unfavourable step	€ 254,383 Retained profit 2025: € 254,383 ▼ 6% vs 2024 (€ 271,659) Unfavourable step	▼ 6%
Dividend	€ 42,000 Dividend 2022: € 42,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 42,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 718,535 Bank debt 2022: € 718,535 First fiscal year in the series	€ 688,356 Bank debt 2023: € 688,356 ▼ 4% vs 2022 (€ 718,535) Favourable step	€ 618,642 Bank debt 2024: € 618,642 ▼ 10% vs 2023 (€ 688,356) Favourable step	€ 585,959 Bank debt 2025: € 585,959 ▼ 5% vs 2024 (€ 618,642) Favourable step	▼ 5%
Balance sheet total	€ 2,178,375 Balance sheet total 2022: € 2,178,375 First fiscal year in the series	€ 1,911,387 Balance sheet total 2023: € 1,911,387 ▼ 12% vs 2022 (€ 2,178,375) Unchanged	€ 1,682,809 Balance sheet total 2024: € 1,682,809 ▼ 12% vs 2023 (€ 1,911,387) Unchanged	€ 1,629,482 Balance sheet total 2025: € 1,629,482 ▼ 3% vs 2024 (€ 1,682,809) Unchanged	▼ 3%
Employees (FTE)	0.8 Employees (FTE) 2022: 0.8 First fiscal year in the series	0.8 Employees (FTE) 2023: 0.8 Unchanged (0.8) Unchanged	0.8 Employees (FTE) 2024: 0.8 Unchanged (0.8) Unchanged	1 Employees (FTE) 2025: 1 ▲ 0.2 vs 2024 (0.8) Unchanged	▲ 0.2

Key figures of BETAMEDICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 May 2027.

What happened to BETAMEDICS?

What happened at BETAMEDICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 Tiemen Darras stepped down as director. NBB
2027 Lies Sobry stepped down as director. NBB
Apr 30, 2026 New annual accounts for financial year 2025: loss of € 17,276. Source: NBB ↗
2021 Tiemen Darras became a director. NBB
2021 Lies Sobry became a director. NBB
Nov 9, 2015 New establishment in Roeselare. KBO
Nov 9, 2015 Start of the company according to the CBE. KBO

In short

From € 81,172 profit in 2022 to € 17,276 loss in 2025.

Paid € 15,191 in corporate taxes since 2022.

Best year ever: 2022, with € 81,172 profit.

On average € 96,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Tiemen Darras

Managing director

since 2021 · until 2027

Lies Sobry

Managing director

since 2021 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Martinusstraat 15

8800 Roeselare

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS betamedics.com

Canonical: https://betamedics.com/en/homepage

Technologies

Adobe FontsDrupalFacebook PixelGoogle AnalyticsPHPjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

AS-HOSTINGER, CY

Domain

betamedics.com

Registered

2015-10-17

Registrar

Key-Systems GmbH

Expires

2026-10-17

Website info

HTTPS Ja

Languages EN

Features

Ads

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number: 0642.736.252
VAT number: BE 0642.736.252
Registered office: Sint-Martinusstraat 15, 8800 Roeselare
Names & denominations: BETAMEDICS
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 9 November 2015
Peppol: Active · Active since 27 Mar 2026
Contact: betamedics.com
Activities · NACE: Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

BETAMEDICS